Target type: molecularfunction
Binds to and increases the activity of a peptidase that is involved in the apoptotic process. [GOC:BHF, GOC:mah, GOC:mtg_apoptosis, GOC:rl]
Peptidase activator activity involved in apoptotic process describes the role of proteins in initiating or regulating the activity of proteases, also known as peptidases, during the process of programmed cell death, or apoptosis. These activators often act by promoting the assembly of the death-inducing complex, a multi-protein structure that triggers the activation of specific caspases, a family of proteases crucial for apoptosis. This activation can occur through various mechanisms, including:
1. **Direct binding:** Some activators directly interact with the inactive pro-caspase molecule, inducing conformational changes that expose the active site and trigger auto-activation.
2. **Scaffolding:** Other activators act as scaffolding proteins, bringing together multiple components of the death-inducing complex, including pro-caspases, adaptor proteins, and other regulatory molecules. This assembly facilitates the activation of caspases through proximity-induced dimerization or by promoting conformational changes.
3. **Release of inhibitors:** Some activators function by displacing or removing inhibitory proteins that block caspase activation.
4. **Regulation of upstream signaling pathways:** Some activators participate in upstream signaling pathways that regulate the assembly and activation of the death-inducing complex. This includes proteins involved in sensing cellular stress, DNA damage, or other apoptotic stimuli.
The precise molecular mechanisms of action vary depending on the specific peptidase activator and the apoptotic pathway involved. However, the ultimate effect is the activation of caspases, leading to the execution of the apoptotic program, characterized by the breakdown of cellular components and the dismantling of the cell. This process plays a crucial role in maintaining tissue homeostasis, eliminating damaged or unwanted cells, and preventing uncontrolled cell growth.'
"
Protein | Definition | Taxonomy |
---|---|---|
Dipeptidyl peptidase 1 | A dipeptidyl peptidase 1 that is encoded in the genome of human. [PRO:DNx, UniProtKB:P53634] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
Pyrrolidine-1-carbonitrile | pyrrolidines | ||
e 64 | E 64: cysteine protease inhibitor of microbial origin, which inhibits cathepsin B (EC 3.4.22.1) and cathepsin L (EC 3.4.22.-) | dicarboxylic acid monoamide; epoxy monocarboxylic acid; guanidines; L-leucine derivative; zwitterion | antimalarial; antiparasitic agent; protease inhibitor |
canertinib | monochlorobenzenes; morpholines; organofluorine compound; quinazolines | antineoplastic agent; tyrosine kinase inhibitor | |
odanacatib | odanacatib: a selective inhibitor of cathepsin K for the treatment of post-menopausal osteoporosis; structure in first source | ||
bibw 2992 | aromatic ether; enamide; furans; monochlorobenzenes; organofluorine compound; quinazolines; secondary carboxamide; tertiary amino compound | antineoplastic agent; tyrosine kinase inhibitor | |
6-(3,5-difluoroanilino)-9-ethyl-2-purinecarbonitrile | 6-aminopurines | ||
6-(3,5-difluoroanilino)-9-(2,2-difluoroethyl)-2-purinecarbonitrile | 6-aminopurines | ||
9-(3,5-difluorophenyl)-6-(ethylamino)-2-purinecarbonitrile | imidazoles | ||
grassystatin a | grassystatin A: isolated from a cyanobacterium, identified as Lyngbya cf.; structure in first source | ||
thiopental sodium | organochlorine compound; piperazines; pyrimidines | antineoplastic agent; tyrosine kinase inhibitor | |
osimertinib | osimertinib : A member of the class of aminopyrimidines that is 4-(1-methylindol-3-yl)pyrimidin-2-amine in which one of the amino hydrogens is replaced by a 2-methoxy-4-[2-(dimethylamino)ethyl](methyl)amino-5-acrylamidophenyl group. Used (as the mesylate salt) for treatment of EGFR T790M mutation positive non-small cell lung cancer. osimertinib: an EGFR tyrosine kinase inhibitor | acrylamides; aminopyrimidine; biaryl; indoles; monomethoxybenzene; secondary amino compound; secondary carboxamide; substituted aniline; tertiary amino compound | antineoplastic agent; epidermal growth factor receptor antagonist |